| Literature DB >> 25852653 |
Yufei Wang1, Yuehua Ke2, Jie Xu3, Ligui Wang2, Tongkun Wang4, Hui Liang1, Wei Zhang1, Chunli Gong2, Jiuyun Yuan2, Yubin Zhuang2, Chang An2, Shuangshuang Lei2, Xinying Du2, Zhoujia Wang2, Wenna Li2, Xitong Yuan2, Liuyu Huang2, Xiaoli Yang1, Zeliang Chen2.
Abstract
Bacterial small non-coding RNAs (sRNAs) are gene expression modulators respond to environmental changes, stressful conditions, and pathogenesis. In this study, by using a combined bioinformatic and experimental approach, eight novel sRNA genes were identified in intracellular pathogen Brucella melitensis. BSR0602, one sRNA that was highly induced in stationary phase, was further examined and found to modulate the intracellular survival of B. melitensis. BSR0602 was present at very high levels in vitro under stresses similar to those encountered during infection in host macrophages. Furthermore, BSR0602 was found to be highly expressed in the spleens of infected mice, suggesting its potential role in the control of pathogenesis. BSR0602 targets the mRNAs coding for gntR, a global transcriptional regulator, which is required for B. melitensis virulence. Overexpression of BSR0602 results in distinct reduction in the gntR mRNA level. B. melitensis with high level of BSR0602 is defective in bacteria intracellular survival in macrophages and defective in growth in the spleens of infected mice. Therefore, BSR0602 may directly inhibit the expression of gntR, which then impairs Brucellae intracellular survival and contributes to Brucella infection. Our findings suggest that BSR0602 is responsible for bacterial adaptation to stress conditions and thus modulate B. melitensis intracellular survival.Entities:
Keywords: Brucella; intracellular survival; post-transcriptional control; small RNA; stress response; virulence
Year: 2015 PMID: 25852653 PMCID: PMC4365724 DOI: 10.3389/fmicb.2015.00164
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Putative sRNA-containing intergenic regions examined by northern blot analysis.
| No. | Predicted sRNA | Chromosome | Gene orientation | Coordinates in 16M genome (5′–3′) | Flanking gene | Predicted length (nt) | Probe location | |
|---|---|---|---|---|---|---|---|---|
| 5′ | 3′ | |||||||
| 1 | BSR1944 | AE008917 | ← ← ← | 2004088-2003970 | BMEI1945 | BMEI1944 | 119 | 2–100 |
| 2 | BSR0742 | AE008918 | → ← → | 781743-781583 | BMEII0743 | BMEII0742 | 161 | 26–133 |
| 3 | BSR0709 | AE008918 | ← ← → | 750924-750608 | BMEII0710 | BMEII0709 | 317 | 159–289 |
| 4 | BSR0653 | AE008918 | → ← → | 684479-683838 | BMEII0654 | BMEII0653 | 642 | 127–307 |
| 5 | BSR1350 | AE008917 | ← ← → | 1405266-1405091 | BMEI1351 | BMEI1350 | 176 | 33–138 |
| 6 | BSR1007 | AE008917 | ← ← ← | 1047074-1046906 | BMEI1008 | BMEI1007 | 169 | 5–144 |
| 7 | BSR0743 | AE008917 | → → → | 769464-769559 | BMEI0742 | BMEI0743 | 96 | 3–74 |
| 8 | BSR0739 | AE008917 | ← → → | 764954-765113 | BMEI0738 | BMEI0739 | 160 | 20–121 |
| 9 | BSR0617 | AE008917 | → → → | 643141-643300 | BMEI0616 | BMEI0617 | 160 | 31–143 |
| 10 | BSR1073 | AE008918 | ← → ← | 1114550-1114745 | BMEII1072 | BMEII1073 | 196 | 33–134 |
| 11 | BSR0322 | AE008917 | → → ← | 330458-330586 | BMEI0321 | BMEI0322 | 129 | 2–119 |
| 12 | BSR0201 | AE008917 | ← → → | 208543-208625 | BMEI0200 | BMEI0201 | 83 | 15–77 |
| 13 | BSR1915 | AE008917 | → → ← | 1969915-1970035 | BMEI1914 | BMEI1915 | 121 | 5–112 |
| 14 | BSR0742 | AE008918 | → → → | 778863-779065 | BMEII0741 | BMEII0742 | 203 | 4–142 |
| 15 | BSR0626 | AE008918 | ← → ← | 661282-661409 | BMEII0625 | BMEII0626 | 128 | 19–118 |
| 16 | BSR0602 | AE008918 | ← → ← | 635956-636124 | BMEII0601 | BMEII0602 | 169 | 33–142 |
| 17 | BSR1141 | AE008917 | ← → ← | 1187552-1187749 | BMEI1140 | BMEI1141 | 198 | 41–176 |
| 18 | BSR0437 | AE008918 | → → → | 456155-456421 | BMEII0436 | BMEII0437 | 267 | 12–227 |
| 19 | BSR1133 | AE008917 | ← → ← | 1176626-1176882 | BMEI1132 | BMEI1133 | 257 | 47–155 |
| 20 | BSR0377 | AE008918 | ← → ← | 392479-392638 | BMEII0376 | BMEII0377 | 160 | 8–139 |
| 21 | BSR0992 | AE008917 | ← → ← | 1034662-1034877 | BMEI0991 | BMEI0992 | 216 | 60–159 |
.
.
Figure 1Experimental verification and expression of the sRNAs in . (A) Northern blots verification for the presence of B. melitensis sRNAs. RNA from stationary phase cultures was analyzed by northern blotting using 3′-end DIG-labeled RNA probe complementary to sRNA candidates. (B) RT-PCR verification of the transcriptional unit of sRNA candidates. RNA prepared from wild-type cells grown to stationary phase at 37°C was used for the RT-PCR reaction. The gene organizations around sRNA genes were classified into three groups as schematically represented; the positions and directions of sRNAs and ORFs were represented by white and black arrows, respectively. The regions to be amplified were shown by bars with numbers. +, with reverse transcriptase; −, without reverse transcriptase. (C) Examination of sRNA expression in B. melitensis 16M and 16MΔhfq with northern blot. Total RNA was extracted from the 16M and 16MΔhfq grown in TSB to exponential phase (E) and early stationary phase (S). Northern blot was performed as described in Section “Materials and Methods.” 5S rRNA was used as a positive control. For each sRNA, northern blot analysis was carried out using at least three different RNA samples to ensure the reproducibility of expression profiles.
Figure 2BSR0602 is expressed under infection related conditions. (A) Growth dependent expression of BSR0602. Total RNA was extracted from B. melitensis 16M grown in TSB to early-exponential stage (E), mid-exponential stage (M), and early stationary phase (S). RNA was isolated and transcription of BSR0602 was quantified by semi-quantitative RT-PCR. The 16S rRNA was used as an internal control. (B) Expression of BSR0602 in vitro environmental stresses. 16M was firstly cultured in TSB (pH7.0) and then subjected to different in vitro environment stresses. RNA was isolated and transcription of BSR0602 was quantified by qRT-PCR. The values of the relative expression, which are the means from triplicate experiments, represent the ratios of the levels of BSR0602 under different in vitro stresses to that under the regular TSB7.0 condition. Asterisks (*) represent significant differences compared with that under TSB7.0. (C) Expression of BSR0602 during mouse infection. BALB/c mice (five per time point) were intraperitoneally infected with B. melitensis 16M and 16MΔhfq, and then the intracellular bacteria were recovered from the spleens at 3, 7, 14, 28, and 42 days post infection, respectively. Total RNA was isolated and subjected to qRT-PCR as described. The values represent the relative level of BSR0602 in 16M or 16MΔhfq recovered from the spleen as compared to the level of BSR0602 in B. melitensis grown to exponential phase in vitro. The asterisks above gray box denote values significantly different from those of in vitro condition, and asterisks above white box represent significant differences between 16M and 16MΔhfq.
Figure 3BSR0602 directly regulates . (A) RT-PCR verification of predicted target mRNA of BSR0602. RNA was isolated from 16M, 16MΔBSR0602, and 16M-BSR0602 and relative transcription of predicted target mRNA genes was quantified and normalized with 16S rRNA. (B) Schematic representation of the proposed BSR0602–BMEI0106 interactions and of compensatory base-pair changes. Numbers indicate relative position to the translational start site of BMEI0106 or position downstream of the transcriptional start site of BSR0602. Arrows denote nucleotide substitutions (in box) introduced to BSR0602 and BMEI0106 mRNA. (C) Regulation of GntR-GFP reporter fusions by BSR0602. E. coli strains carrying only a gfp fusion plasmid, or with a combination of both the gfp fusion plasmid and sRNA-encoding plasmid, were grown in LB broth, and immunoblot analyses were carried out on total protein lysates to detect levels of GFP or GroEL. Compensatory base pair exchange used for confirming the BSR0602–gntR interaction was also tested by immunoblot analyses. mBSR0602 means mutant BSR0602; mgntR means mutant gntR.
Figure 4BSR0602 regulation . (A) Contribution of GntR (BMEI0106) to the virulence of B. melitensis. Groups of five BALB/c mice were infected intraperitoneally with 2 × 106 CFU of 16M, 16MΔgntR, or 16MΔgntR-C. At 7, 14, 28, and 45 days post inoculation, the spleens were aseptically removed and the CFU were counted by plating serial dilutions on TSA plates. The data were expressed as the mean log10 CFU ± SD (n = 5). Significant differences between the mutant and parent strain were indicated as follows: *P < 0.001. (B) Expression of gntR during mouse infection. BALB/c mice (five per time point) were intraperitoneally infected with B. melitensis 16M, and total RNA was isolated and subjected to assays of qRT-PCR as described above. The values represent the relative level of gntR in 16M recovered from the spleen as compared to the level of gntR in B. melitensis grown to exponential phase in vitro. The SD is indicated by the error bars.
Figure 5BSR0602 is involved in . (A) Expression of BSR0602 reduces in vitro stress resistance of B. melitensis. 16M, 16MΔBSR0602, and 16M-BSR0602 were grown in TSB to the early logarithmic phase and then subjected to different stress conditions. After the treatments, the surviving bacteria were enumerated by plating serial dilutions onto TSA plates. Bars represent mean percent survival compared to untreated controls, and error bars represent standard errors of percent survival from three replicates. Asterisks (*) represent significant differences compared with 16M. (B) Expression of BSR0602 reduces the number of bacteria in spleens of infected mice. Mice were challenged with BSR0602 mutants and parental 16M (or BSR0602 overexpression strains and parental 16M) in a competitive index model of infection. Twenty-four hours post infection, spleens were removed and the bacterial amount for each strain was determined. Each data point represent a single mouse. (C) Expression of BSR0602 reduces intracellular multiplication of B. melitensis. Murine macrophage-like cells RAW264.7 were incubated with a 1:1 ratio of 16M to 16MΔBSR0602 or 16M-BSR0602. Data are presented as the log10 of the ratios of mutant to wild-type CFU from serial dilutions plated in duplicate and averaged over five wells. Error bars represent SD from the means. The limit of detection was <25 CFU/well.